CDMOs have been some of the biggest winners from COVID contracts and will see benefits for several more years to come. A Q&A with GlobalData’s Peter Shapiro.
35-year pharmaceutical industry veteran brings deep industry expertise and a track record of building successful, client-centric, growth organizations.
Hiring is up, recruiters say, and soft skills are in short supply. Survey respondents say they’re happy now, but will likely change employers within five years.
David A. Linn has been named director of business intelligence and business development for Jubilant HollisterStier’s Contract Manufacturing & Services Division.
Fujifilm Corp. and Merck have entered into a definitive agreement under which Fujifilm will acquire the Merck BioManufacturing Network, a provider of contract manufacturing and development services for the biopharma industry.
Grant Gilker has been named general manager of operations at DPT’s Center of Excellence for semi-solids and liquids manufacturing facility in San Antonio, TX.
An affiliate of Sun European Partners, LLP has entered into an agreement to acquire NextPharma Technologies Holding Ltd., a global provider of contract manufacturing, product development, clinical trials and logistics services to the pharmaceutical and bi
Pharmaceutical Packaging Systems sales were $200.9 million in the quarter (+6%) attributed to growth in sales of Westar-processed, FluroTec- and Teflon-coated products, as well as sales of Envision.
Albemarle Corp. has entered a partnership with PharmaCore to provide manufacturing capabilities for customers with projects that require high volume capacity.
NextPharma has engaged the services of Ron Collins to represent its business development affairs in the eastern part of the U.S. and Canada in order to meet increased demand for its contract outsourcing services.
Alliance Medical Products, Inc. (AMP) has opened its East Coast sales office located in Howell, NJ, and appointed Thomas J. Puskar as associate director and East Coast account executive.
Cory Lewis has been named director of business development for the global biopharmaceutical contract development and manufacturing division of Cook Medical.
TcL Pharma and Lonza have signed a development and supply contract for TcL Pharmas lead drug candidate, a monoclonal antibody that adjusts the immune system for the potential treatment of graft rejections and patients with auto-immune diseases.
The parenteral drug sector is driven by new cancer drugs and a considerable number of biologics. Veteran performers, like Baxter Biopharma, brace for growth.
Biologics capacity may be in short supply just as biopharma products head to commercial manufacture. Learn how to plan protein production in a resource-constrained environment